Aanesthetic Agents for Day Surgery - NIHR Health Technology ...
Aanesthetic Agents for Day Surgery - NIHR Health Technology ...
Aanesthetic Agents for Day Surgery - NIHR Health Technology ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Clinical outcome data<br />
PONV by anaesthetic regimen<br />
The incidence of PONV was analysed to assess<br />
whether the risk of PONV differed between the<br />
anaesthetic regimens. First, the crude (unadjusted)<br />
figures were tabulated. Further tables in appendix<br />
26 display the association between PONV and<br />
other variables that plausibly might be associated<br />
with risk. Logistic regression analysis was employed<br />
to confirm the impression portrayed<br />
by the tabular analyses. It also adjusted the<br />
estimates of PONV risk to allow <strong>for</strong> any residual<br />
effects of the potential confounding variables<br />
that might arise from them not being exactly<br />
evenly distributed across the randomisation<br />
arms. The total numbers of subjects shown in<br />
the tables vary slightly, since some of the variables<br />
have missing data. Probability values presented<br />
with tables refer, unless otherwise stated, to a<br />
simple test <strong>for</strong> heterogeneity among categories.<br />
So-called ‘exact’ tests were employed when<br />
appropriate. Probability values are not<br />
TABLE 22 The occurrence of any PONV by anaesthetic regimen in the adult study<br />
© Queen’s Printer and Controller of HMSO 2002. All rights reserved.<br />
<strong>Health</strong> <strong>Technology</strong> Assessment 2002; Vol. 6: No. 30<br />
presented <strong>for</strong> tables examining the distribution<br />
of potential confounding variables among the<br />
randomisation categories, as the statistical significance<br />
of observed differences is not relevant to<br />
the question of confounding.<br />
Tables 22 and 23 give the occurrence of PONV,<br />
at varying degrees of severity, within the randomisation<br />
categories. For all PONV and <strong>for</strong> one or<br />
more episodes of vomiting a substantially larger<br />
proportion of cases occurred with the sevoflurane/<br />
sevoflurane regimen than with the others: 30%<br />
of the sevoflurane/sevoflurane category suffered<br />
PONV compared to 20% overall. Propofol/<br />
propofol appears to have the lowest (crude)<br />
incidence of PONV. Using this as the reference<br />
category the odds ratio (OR) <strong>for</strong> PONV in the<br />
sevoflurane/sevoflurane category is 2.7,<br />
suggesting a nearly three-fold risk of PONV.<br />
When one or more episodes of vomiting is<br />
considered the OR appears to be 6.14. However,<br />
this estimate is based on a small number of<br />
events, and is unreliable.<br />
TABLE 23 The occurrence of one or more episodes of vomiting by anaesthetic regimen in the adult study<br />
Anaesthetic regimen Total<br />
Propofol/ Propofol/ Propofol/ Sevoflurane/<br />
propofol isoflurane sevoflurane sevoflurane<br />
Total No. of patients 265 (100%) 267 (100%) 280 (100%) 251 (100%) 1063 (100%)<br />
One or more episodes<br />
of vomiting – no<br />
260 (98.1%) 253 (94.8%) 270 (96.4%) 225 (89.6%) 1008 (94.8%)<br />
One or more episodes<br />
of vomiting – yes<br />
5 (1.9%) 14 (5.2%) 10 (3.6%) 26 (10.4%) 55 (5.2%)<br />
OR *<br />
1.00 2.88 1.96 6.14 –<br />
(0.96–10.34) (0.60–7.41) (2.26–20.75)<br />
* Calculated using propofol/propofol as reference<br />
Anaesthetic regimen Total<br />
Propofol/ Propofol/ Propofol/ Sevoflurane/<br />
propofol isoflurane sevoflurane sevoflurane<br />
Total No. of patients 265 (100%) 267 (100%) 280 (100%) 251 (100%) 1063 (100%)<br />
Nausea or vomiting – no 228 (86.0%) *<br />
218 (81.6%) †<br />
234 (83.6%) ‡<br />
176 (70.1%) *†‡ 856 (80.5%)<br />
Nausea or vomiting – yes 37 (14.0%) 49 (18.4%) 46 (16.4%) 75 (29.9%) 207 (19.5%)<br />
OR §<br />
* Versus sevoflurane/sevoflurane,p = 0.001; versus other arms, not significant<br />
† Versus sevoflurane/sevoflurane,p = 0.003; versus other arms, not significant<br />
‡ Versus sevoflurane/sevoflurane,p = 0.001; versus other arms, not significant<br />
§ Calculated using propofol/propofol as reference<br />
1.00 1.38 (0.85–2.27) 1.24 (0.75–2.04) 2.69 (1.70–4.31) –<br />
49